Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity*

The action of Clostridium difficile toxins A and B depends on processing and translocation of the catalytic glucosyltransferase domain into the cytosol of target cells where Rho GTPases are modified. Here we studied the processing of the toxins. Dithiothreitol and β-mercaptoethanol induced auto-cleavage of purified native toxin A and toxin B into ∼250/210- and ∼63-kDa fragments. The 63-kDa fragment was identified by mass spectrometric analysis as the N-terminal glucosyltransferase domain. This cleavage was blocked by N-ethylmaleimide or iodoacetamide. Exchange of cysteine 698, histidine 653, or aspartate 587 of toxin B prevented cleavage of full-length recombinant toxin B and of an N-terminal fragment covering residues 1–955 and inhibited cytotoxicity of full-length toxin B. Dithiothreitol synergistically increased the effect of myo-inositol hexakisphosphate, which has been reported to facilitate auto-cleavage of toxin B (Reineke, J., Tenzer, S., Rupnik, M., Koschinski, A., Hasselmayer, O., Schrattenholz, A., Schild, H., and Von Eichel-Streiber, C. (2007) Nature 446, 415–419). N-Ethylmaleimide blocked auto-cleavage induced by the addition of myo-inositol hexakisphosphate, suggesting that cysteine residues are essential for the processing of clostridial glucosylating toxins. Our data indicate that clostridial glucosylating cytotoxins possess an inherent cysteine protease activity related to the cysteine protease of Vibrio cholerae RTX toxin, which is responsible for auto-cleavage of glucosylating toxins.

[1]  S. Tenzer,et al.  Autocatalytic cleavage of Clostridium difficile toxin B , 2007, Nature.

[2]  Lei Wei,et al.  The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. , 1991, The Journal of biological chemistry.

[3]  M. Palcic,et al.  Carbohydrate recognition by Clostridium difficile toxin A , 2006, Nature Structural &Molecular Biology.

[4]  I. Just,et al.  Cellular stability of Rho‐GTPases glucosylated by Clostridium difficile toxin B , 2006, FEBS letters.

[5]  K. Ng,et al.  Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[7]  C. von Eichel-Streiber,et al.  Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. , 1990, Gene.

[8]  K. Aktories,et al.  Clostridium difficile Toxin B as a Probe for Rho GTPases , 2008 .

[9]  J. Johnson,et al.  Molecular characterization of the Clostridium difficile toxin A gene , 1990, Infection and immunity.

[10]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[11]  K. Aktories,et al.  Isotype-specific Degradation of Rac Activated by the Cytotoxic Necrotizing Factor 1* , 2004, Journal of Biological Chemistry.

[12]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[13]  R. Benz,et al.  Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells* , 2001, The Journal of Biological Chemistry.

[14]  Karla J. F. Satchell,et al.  Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain , 2007, The EMBO journal.

[15]  J. Bartlett,et al.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. , 1977, The Journal of infectious diseases.

[16]  H. Urlaub,et al.  Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. , 2005, Microbiology.

[17]  K. Aktories,et al.  Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. , 2007, Glycobiology.

[18]  P. Clark,et al.  Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. , 2007, Journal of molecular biology.

[19]  H. Kuramitsu,et al.  Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases , 1992, Journal of bacteriology.

[20]  F. Eng,et al.  Characterization of the Enzymatic Properties of the First and Second Domains of Metallocarboxypeptidase D* , 1999, The Journal of Biological Chemistry.

[21]  T. Wilkins,et al.  Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin , 1987, Infection and immunity.

[22]  C. Rice,et al.  Structure of the catalytic domain of the hepatitis C virus NS2-3 protease , 2006, Nature.

[23]  J. Ballard,et al.  Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.

[24]  P. Boquet,et al.  Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. , 1996, Trends in microbiology.

[25]  S. Munro,et al.  A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins* , 1998, The Journal of Biological Chemistry.

[26]  T. Wilkins,et al.  Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. , 1994, Microbial pathogenesis.

[27]  I. Just,et al.  Large clostridial cytotoxins. , 2004, Reviews of physiology, biochemistry and pharmacology.

[28]  K. Aktories,et al.  Cellular Uptake of Clostridium difficile Toxin B , 2003, Journal of Biological Chemistry.

[29]  K. Aktories Bacterial toxins : tools in cell biology and pharmacology , 1997 .

[30]  G. Schulz,et al.  Structural basis for the function of Clostridium difficile toxin B. , 2005, Journal of molecular biology.